- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06909422
Mobile Thinking Intervention: A Inital Test
June 25, 2026 updated by: Lauren Luther, University of Alabama at Birmingham
A Mobile Intervention to Enhance Your Mood: A Test of the Acceptability and Efficacy
This study will test the inital efficacy of a brief mobile intervention targeting biased thinking.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lauren Luther
- Phone Number: 205-530-1117
- Email: cas-treatlab@uab.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35223-1517
- University of Alabama at Birmingham
-
Contact:
- Lauren Luther
- Phone Number: 205-530-1117
- Email: cas-treatlab@uab.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of schizophrenia or related psychotic disorder OR
- Identified as being at clinical high risk for psychosis in symptom interviews
Exclusion Criteria:
- Recent changes in mental health treatment in past month or two months if on depot
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile Intervention to Target Biased Thinking
|
This intervention will be delivered via a mobile application.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Defeatist Beliefs Scale - 15
Time Frame: Measured at Baseline and post intervention (6 weeks)
|
Measure of Defeatist Performance Beliefs
|
Measured at Baseline and post intervention (6 weeks)
|
|
Brief Negative Symptoms Scale
Time Frame: Measured at Baseline and post intervention (6 weeks)
|
Measure of negative symptoms
|
Measured at Baseline and post intervention (6 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
March 27, 2025
First Submitted That Met QC Criteria
March 27, 2025
First Posted (Actual)
April 3, 2025
Study Record Updates
Last Update Posted (Actual)
June 29, 2026
Last Update Submitted That Met QC Criteria
June 25, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300013893
- Internal Award (Other Grant/Funding Number: University of Alabama at Birmingham)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Will be shared upon reasonable request
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.